Investor Relations

Press Release

AAC Holdings to Open New Detoxification Unit in New Orleans East Hospital

Company Release - 9/29/2017 6:30 AM ET

BRENTWOOD, Tenn., Sept. 29, 2017 /PRNewswire/ -- AAC Holdings, Inc. (NYSE: AAC) has received licensure for its new Townsend Recovery Center New Orleans in New Orleans, Louisiana. The 36-bed facility, which is leased from New Orleans East Hospital, is scheduled to open on October 9, 2017.

Located on the 5th floor of the hospital, Townsend Recovery Center New Orleans will offer 36 beds, provide detoxification and residential treatment services and will be operated by Townsend clinical staff.

"We are proud to work with New Orleans East Hospital to fill a critical community need," noted Michael Cartwright, Chairman and Chief Executive Officer of AAC Holdings, Inc. "It is our mission to transform lives. We know that a long-term recovery is possible and that there is hope for those affected by this disease. The additional beds will enable us to support Townsend Treatment Centers and Townsend Outpatient Center as well as other treatment providers in Louisiana."

Townsend, part of the American Addiction Centers' family of treatment centers, is a leading provider of treatment services in south Louisiana and is known for its innovative treatment model - The Townsend Way. This personalized treatment approach includes addressing the genetic components of addiction and utilizing pharmacogenetics to give physicians vital information about which medications will be most useful for each patient.  

About New Orleans East Hospital

Built in 2014, the 80-bed New Orleans East Hospital is situated on the site of the former Pendleton Memorial Methodist Hospital that was devastated by Hurricane Katrina in 2005. The hospital is operated by Louisiana Children's Medical Center.

About American Addiction Centers

American Addiction Centers is a leading provider of inpatient and outpatient substance abuse treatment services. We treat clients who are struggling with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues. We currently operate substance abuse treatment facilities located throughout the United States. These facilities are focused on delivering effective clinical care and treatment solutions. For more information, please find us at or follow us on Twitter @AAC_Tweet.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are made only as of the date of this release. In some cases, you can identify forward-looking statements by terms such as "anticipates," "believes," "could," "estimates," "expects," "may," "potential," "predicts," "projects," "should," "will," "would," and similar expressions intended to identify forward-looking statements, although not all forward-looking statements contain these words. Forward-looking statements may include information concerning AAC Holdings, Inc.'s (collectively with its subsidiaries; "Holdings" or the "Company") possible or assumed future results of operations, including descriptions of Holdings' revenues, profitability, outlook and overall business strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from the information contained in the forward-looking statements. These risks, uncertainties and other factors include, without limitation: (i) our inability to operate our facilities; (ii) our reliance on our sales and marketing program to continuously attract and enroll clients; (iii) a reduction in reimbursement rates by certain third-party payors for inpatient and outpatient services and point of care and definitive lab testing; (iv) an increase in our provision for doubtful accounts based on the aging of receivables;  (v) our failure to successfully achieve growth through acquisitions and de novo expansions; (vi) uncertainties regarding the timing of the closing of acquisitions; (vii) the possibility that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of an acquisition; (viii) our failure to achieve anticipated financial results from prior acquisitions; (ix) a disruption in our ability to perform definitive drug testing services; (x) maintaining compliance with applicable regulatory authorities, licensure and permits to operate our facilities and lab; (xi) a disruption in our business and reputation and potential economic consequences with the civil securities claims brought by shareholders or other litigation or investigative proceedings; (xii) our inability to meet our covenants in the loan documents; (xiii) our inability to integrate newly acquired facilities; and (xiv) general economic conditions, as well as other risks discussed in the "Risk Factors" section of the Company's Annual Report on Form 10-K, and other filings with the Securities and Exchange Commission. As a result of these factors, we cannot assure you that the forward-looking statements in this release will prove to be accurate. Investors should not place undue reliance upon forward looking statements.

View original content:

SOURCE AAC Holdings, Inc.